期刊文献+

220例痰假丝酵母菌属培养阳性患者抗真菌治疗分析 被引量:5

Antifungal treatemt of Candiacultured positive from sputum of 220 patients
原文传递
导出
摘要 目的探讨并分析临床对痰假丝酵母菌属培养阳性患者的治疗情况,为临床医师抗真菌感染治疗提供依据。方法采用回顾性调查方法,对220例痰假丝酵母菌属培养阳性患者抗真菌治疗病例资料进行统计、归纳、分析。结果 220株假丝酵母菌属中,白色假丝酵母菌158株,占71.8%;进行影像检查179例,占81.4%;220例痰假丝酵母菌属培养阳性患者,符合确诊病例仅1例,占0.5%;符合临床诊断病例为2例,占0.9%;疑似病例217例,占98.7%;220例患者中133例进行了预防性抗真菌治疗;科室排序依次为呼吸内科、内科监护病房、肺部肿瘤科。结论综合分析假丝酵母菌属感染患者临床症状、影像学及实验室检测结果,才能进行科学的诊断分级,给予早期积极有效的治疗。 OBJECTIVE To explore and analyze the treatment of the patients who were with sputum culture positive of Candida,so as to provide basis for antifungal treatment.METHODS By the means of retrospective survey,the clinical data of 220 patients whose sputum were cultured positive for Candida were analyzed and susmurized statistically.RESULTS Of 220 strains of Candida,there were 158(71.8%) C.albicans isolates;totally 179(81.4%) cases underwent imaging examination;among the 220 cases of sputum culture Candida positive,only one(0.5%) case was confirmed;there were 2(0.9%) cases who were in line with confirmed cases;there were 217(98.7%) suspected cases;among the 220 patients,totally 133 patients underwent preventive antifungal treatment;the clinical departments were in order as follows:department of respiratory medicine,internal medicine care unit,and department of pulmonary tumors.CONCLUSION To comprehensively analyze the clinical symptoms of tha patients with Candida infections and the results of imaging examination and laboratory test can ensure the scientific classification of diagnosis and effective treatment in early stage.
机构地区 解放军第 解放军
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2012年第6期1303-1305,共3页 Chinese Journal of Nosocomiology
关键词 痰培养 假丝酵母菌属 抗真菌治疗 分析 Sputum culture Candida Antifungal treatment Analysis
  • 相关文献

参考文献12

二级参考文献48

共引文献1170

同被引文献36

  • 1刘亚新,王亚霞,魏琴.重症监护病房获得性念珠菌感染的临床分布及耐药分析[J].中华医院感染学杂志,2005,15(12):1417-1419. 被引量:11
  • 2徐修礼,杨佩红,孙怡群,樊新.深部真菌感染的菌群分布及耐药性[J].中华医院感染学杂志,2007,17(3):349-351. 被引量:50
  • 3Clinical and Laborarory Standards Institute. Performance stand- ards for antimlcrobial susceptibility testing, twentieth information- al supplement[S]. CLSI,2010.
  • 4Zheng P, Somersan-Karakaya S, Lu S, et al. Synthetic calanolides with bactericidal activity against replicating and nonreplicating Mycobacterium tuberculosis[J]. J Med Chem,2014,57(9):3755-72.
  • 5Moser S, Johnsson K.Yeast three-hybrid screening for identifying anti -tuberculosis drug targets [J]. Chembiochem,2013,25; 14 (17): 2239-2242.
  • 6Favrot L, Grzegorzewicz AE, Lajiness DH, et al.Meehanism of in- hibition of Mycobaeterium tuberculosis antigen 85 by ebselen. Nat Commun. 2013,4:2748.
  • 7Shih RY, Koeller KK.Bacterial, Fungal, and Parasitic Infections of the Central Nervous System: Radiologic-Pathologic Correlation and Historical Perspectives[J].Radiographics,2015,12:140317.
  • 8Sreejit G, Ahmed A, Parveen N, et al. The ESAT-6 protein of My- cobacterium tuberculosis interacts with beta-2-microglobulin (132M) affecting antigen presentation function of macrophage [J]. PLoS Pathog,2014,10( 10):e 1004446.
  • 9Clinical and Laboratory Standards Institure. Performance Standards for Antimicrobial Susceptibility testing [S]. 2011.
  • 10Zhang X, Wang R, Di X, et al. Different microbiological and clinical aspects of lower respiratory tract infections between China and European/American countries [J]. J Thorac Dis, 2014, 6(2): 134-142.

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部